NO20090780L - Human Glp-1 mimetistoff, sammensetninger, fremgangsmater og anvendelser - Google Patents
Human Glp-1 mimetistoff, sammensetninger, fremgangsmater og anvendelserInfo
- Publication number
- NO20090780L NO20090780L NO20090780A NO20090780A NO20090780L NO 20090780 L NO20090780 L NO 20090780L NO 20090780 A NO20090780 A NO 20090780A NO 20090780 A NO20090780 A NO 20090780A NO 20090780 L NO20090780 L NO 20090780L
- Authority
- NO
- Norway
- Prior art keywords
- mimetic
- methods
- glp
- compositions
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Abstract
Foreliggende oppfinnelse angår minst ett forbedret, humant GLP-I-mimetistoff eller spesifisert del eller variant som inkluderer isolerte nukleinsyrer som koder minst ett GLP-I-mimetistoff eller spesifisert del eller variant, GLP-I-mimetistoff eller spesifisert del eller varianter, vektorer, vertsceller, transgene mus eller planter og fremgangsmåter for fremstilling og anvendelse derav som inkluderer terapeutiske sammensetninger, fremgangsmåter og innretninger.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83170406P | 2006-07-18 | 2006-07-18 | |
PCT/US2007/073752 WO2008011446A2 (en) | 2006-07-18 | 2007-07-18 | Human glp-1 mimetibodies, compositions, methods and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090780L true NO20090780L (no) | 2009-04-03 |
Family
ID=38596585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090780A NO20090780L (no) | 2006-07-18 | 2009-02-18 | Human Glp-1 mimetistoff, sammensetninger, fremgangsmater og anvendelser |
Country Status (18)
Country | Link |
---|---|
US (2) | US20090325873A1 (no) |
EP (1) | EP2049567A2 (no) |
JP (1) | JP2010500868A (no) |
KR (1) | KR20090039787A (no) |
CN (1) | CN101535341A (no) |
AR (1) | AR061930A1 (no) |
AU (1) | AU2007275294A1 (no) |
BR (1) | BRPI0714334A2 (no) |
CA (1) | CA2658286A1 (no) |
CR (1) | CR10619A (no) |
EA (1) | EA200970131A1 (no) |
EC (1) | ECSP099079A (no) |
MX (1) | MX2009000748A (no) |
NO (1) | NO20090780L (no) |
TW (1) | TW200821386A (no) |
UY (1) | UY30494A1 (no) |
WO (1) | WO2008011446A2 (no) |
ZA (1) | ZA200901132B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1412384B1 (en) * | 2001-06-28 | 2007-12-26 | Novo Nordisk A/S | Stable formulation of modified glp-1 |
MY149546A (en) | 2007-11-02 | 2013-09-13 | Novartis Ag | Improved nogo-a binding molecules and pharmaceutical use tereof |
JP5604297B2 (ja) * | 2008-06-17 | 2014-10-08 | 株式会社糖鎖工学研究所 | 糖鎖付加glp−1ペプチド |
JO2870B1 (en) | 2008-11-13 | 2015-03-15 | ميرك شارب اند دوهم كورب | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes |
LT2373681T (lt) | 2008-12-10 | 2017-04-10 | Glaxosmithkline Llc | Albiglutido farmacinės kompozicijos |
WO2010096394A2 (en) | 2009-02-17 | 2010-08-26 | Redwood Biosciences, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
US20100291160A1 (en) * | 2009-05-13 | 2010-11-18 | Carver David R | Pharmaceutical system for trans-membrane delivery |
WO2011028455A1 (en) | 2009-09-02 | 2011-03-10 | Merck Sharp & Dohme Corp. | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
US8853212B2 (en) | 2010-02-22 | 2014-10-07 | Merck Sharp & Dohme Corp | Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
JP5908888B2 (ja) | 2010-04-16 | 2016-04-26 | ヤンセン バイオテツク,インコーポレーテツド | 改変された植物のシステインプロテアーゼ及びその使用 |
JP2013525491A (ja) | 2010-05-04 | 2013-06-20 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 心血管障害を治療または予防し心血管保護を提供する方法 |
US8980929B2 (en) | 2010-05-21 | 2015-03-17 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
AU2012205301B2 (en) | 2011-01-14 | 2017-01-05 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
IN2014DN09640A (no) | 2012-04-16 | 2015-07-31 | Kaneq Pharma Inc | |
CN103204944B (zh) * | 2013-03-26 | 2014-05-28 | 江苏健德生物药业有限公司 | 用于治疗糖尿病的长效免疫融合蛋白 |
WO2017189432A1 (en) | 2016-04-26 | 2017-11-02 | R.P. Scherer Technologies, Llc | Antibody conjugates and methods of making and using the same |
WO2019036859A1 (zh) * | 2017-08-21 | 2019-02-28 | 中国科学院动物研究所 | 分泌glp-1及其衍生物的蛋白表达系统及其制备方法和用途 |
CN111050750A (zh) | 2017-08-24 | 2020-04-21 | 诺沃挪第克公司 | Glp-1组合物及其用途 |
TWI639987B (zh) * | 2017-10-11 | 2018-11-01 | 奇美醫療財團法人奇美醫院 | 具有位置感知的穿刺輔助教學裝置 |
TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
CN113226351A (zh) * | 2018-10-22 | 2021-08-06 | 詹森药业有限公司 | 胰高血糖素样肽1(glp1)-生长分化因子15(gdf15)融合蛋白及其用途 |
EP4106727A1 (en) | 2020-02-18 | 2022-12-28 | Novo Nordisk A/S | Pharmaceutical formulations |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
US5545618A (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
US5512549A (en) | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
US5723125A (en) | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
DE122009000079I2 (de) | 1996-08-30 | 2011-06-16 | Novo Nordisk As Novo Alle | Glp-1 derivate |
US6849719B2 (en) * | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
JP2000319297A (ja) * | 1999-03-30 | 2000-11-21 | Noguchi Inst | 酵素的に安定な複合糖ペプチドの調製法 |
EA003922B1 (ru) | 1999-05-17 | 2003-10-30 | Конджачем, Инк. | Продолжительно действующие инсулинотропные пептиды |
HU229208B1 (en) | 2000-06-16 | 2013-09-30 | Lilly Co Eli | Glucagon-like peptide-1 analogs |
BR0116024A (pt) | 2000-12-07 | 2005-12-13 | Lilly Co Eli | Proteìna de fusão heteróloga e uso da mesma |
CN1363654A (zh) | 2001-07-19 | 2002-08-14 | 上海华谊生物技术有限公司 | 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法 |
JP2005536992A (ja) * | 2002-06-28 | 2005-12-08 | セントカー・インコーポレーテツド | 哺乳動物のepo模倣ch1欠失ミメティボディ、組成物、方法および使用 |
EP1559724A4 (en) | 2002-10-11 | 2006-02-08 | Sanwa Kagaku Kenkyusho Co | GLP-1 DERIVATIVES AND TRANSMUCOSAL ABSORPTION PREPARATIONS THEREOF |
CA2531482A1 (en) | 2003-06-30 | 2005-01-20 | Centocor, Inc. | Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
EP1750754A4 (en) * | 2004-03-31 | 2010-09-22 | Centocor Ortho Biotech Inc | HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES |
-
2007
- 2007-07-18 CA CA002658286A patent/CA2658286A1/en not_active Abandoned
- 2007-07-18 AU AU2007275294A patent/AU2007275294A1/en not_active Abandoned
- 2007-07-18 US US12/305,034 patent/US20090325873A1/en not_active Abandoned
- 2007-07-18 US US11/779,316 patent/US8071103B2/en not_active Expired - Fee Related
- 2007-07-18 EA EA200970131A patent/EA200970131A1/ru unknown
- 2007-07-18 AR ARP070103214A patent/AR061930A1/es unknown
- 2007-07-18 BR BRPI0714334-6A patent/BRPI0714334A2/pt not_active IP Right Cessation
- 2007-07-18 WO PCT/US2007/073752 patent/WO2008011446A2/en active Application Filing
- 2007-07-18 MX MX2009000748A patent/MX2009000748A/es unknown
- 2007-07-18 JP JP2009520970A patent/JP2010500868A/ja active Pending
- 2007-07-18 TW TW096126255A patent/TW200821386A/zh unknown
- 2007-07-18 CN CNA2007800342628A patent/CN101535341A/zh active Pending
- 2007-07-18 KR KR1020097003122A patent/KR20090039787A/ko not_active Application Discontinuation
- 2007-07-18 EP EP07799669A patent/EP2049567A2/en not_active Withdrawn
- 2007-07-19 UY UY30494A patent/UY30494A1/es unknown
-
2009
- 2009-01-19 EC EC2009009079A patent/ECSP099079A/es unknown
- 2009-02-17 ZA ZA200901132A patent/ZA200901132B/xx unknown
- 2009-02-18 CR CR10619A patent/CR10619A/es not_active Application Discontinuation
- 2009-02-18 NO NO20090780A patent/NO20090780L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2007275294A1 (en) | 2008-01-24 |
EP2049567A2 (en) | 2009-04-22 |
ZA200901132B (en) | 2010-10-27 |
EA200970131A1 (ru) | 2009-08-28 |
KR20090039787A (ko) | 2009-04-22 |
UY30494A1 (es) | 2008-01-31 |
MX2009000748A (es) | 2009-03-31 |
US20090325873A1 (en) | 2009-12-31 |
AR061930A1 (es) | 2008-10-01 |
CA2658286A1 (en) | 2008-01-24 |
BRPI0714334A2 (pt) | 2013-05-14 |
TW200821386A (en) | 2008-05-16 |
JP2010500868A (ja) | 2010-01-14 |
ECSP099079A (es) | 2009-02-27 |
WO2008011446A2 (en) | 2008-01-24 |
WO2008011446A3 (en) | 2008-09-18 |
CR10619A (es) | 2009-06-04 |
CN101535341A (zh) | 2009-09-16 |
US8071103B2 (en) | 2011-12-06 |
US20080044411A1 (en) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090780L (no) | Human Glp-1 mimetistoff, sammensetninger, fremgangsmater og anvendelser | |
NO20064953L (no) | Human GLP-1 mimetilegemer, sammensetninger, fremgangsmater og anvendelser | |
NO20073814L (no) | GLP-1-agonister, sammensetninger, fremgangsmater og anvendelser | |
NO20076563L (no) | Anti- MCP-1 antistoffer, sammensetninger og anvendelser | |
MX2010004179A (es) | Anticuerpos anti-amiloide, composiciones, metodos y usos. | |
UA101301C2 (ru) | ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ | |
NO20090596L (no) | Antivirale fosfinatforbindelser | |
AR059257A1 (es) | Genes para mejorar la eficiencia de la utilizacion de nitrogeno en los cultivos | |
DK2459216T3 (da) | Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer | |
BRPI0921665A2 (pt) | humanizado anti-il-6 anticorpos | |
BRPI1010880A2 (pt) | polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos. | |
CU24570B1 (es) | Proteínas de bacillus thuringiensis quiméricas insecticidas tóxicas o inhibidoras de plagas de lepidópteros | |
CO7010783A2 (es) | Proteína naglu humana recombinante y usos de la misma | |
AR061685A1 (es) | Plantas de cultivo transgenicas con mayor tolerancia al estres | |
CY1116413T1 (el) | Καινοφανη πληρως-ανθρωπινα μονοκλωνικα αντισωματα anti-vap-1 | |
AR051444A1 (es) | Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos | |
BRPI0510045A (pt) | seqüência regulatórias para expressar produtos genéticos em planta | |
AR053893A1 (es) | Plantas con caracteristicas de crecimiento mejorado y metodo para desarrollar las mismas | |
MX2009007565A (es) | Uso de genes de trehalasa para proporcionar a las plantas resistencia contra nematodos. | |
AR065243A1 (es) | Composiciones y metodos que utilizan arn de interferencia para el control de nematodos | |
PE20220960A1 (es) | Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros | |
MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
MX2009006892A (es) | Uso de agonistas del receptor de peptido similar al glucagon de tipo 1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles de lipidos. | |
BR112019002586A2 (pt) | proteínas inseticidas | |
BR112019008284A2 (pt) | proteínas inseticidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |